Literature DB >> 8849654

In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood.

S C Chang1, Y C Chen, K T Luh, W C Hsieh.   

Abstract

In vitro activities of 15 antimicrobial agents against 90 strains of Acinetobacter baumannii isolated from blood cultures from hospitalized patients were determined using the agar dilution method. Imipenem, ofloxacin, and ciprofloxacin had the best antimicrobial activity with minimum inhibitory concentrations (MIC50s) of 0.25 mu g/ml and MIC90s of 0.5-1 mu g/ml. beta-lactam antibiotics other than imipenem had poor activity, with MIC50s ranging from 8 to 64 mu g/ml and MIC90s from 32 to > or = 256 mu g/ml. The checkerboard titration method was used to study the effects of combination of two antimicrobial agents. Combinations of ceftazidime, aztreonam, imipenem, or ciprofloxacin with amikacin showed either synergistic effects or partial synergistic effects for 40.9%-86.4% of 22 tested strains. The best in vitro activity was observed with the combination of imipenem and amikacin. No antagonistic effects were observed with the combination of imipenem and amikacin. Synergistic effects were confirmed by time-kill curve studies. In conclusion, imipenem, ofloxacin, and ciprofloxacin were the three most active agents against human blood isolates of A. baumannii. The combination of a beta-lactam or ciprofloxacin with amikacin was synergistic for some of the isolates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8849654     DOI: 10.1016/0732-8893(95)00170-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.

Authors:  T C Chang; A H Huang
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 2.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

3.  Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.

Authors:  M B Marques; E S Brookings; S A Moser; P B Sonke; K B Waites
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 4.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus in vitro.

Authors:  Dae-Ki Joung; Ok-Hwa Kang; Yun-Soo Seo; Tian Zhou; Young-Seob Lee; Sin-Hee Han; Su-Hyun Mun; Ryong Kong; Ho-Jun Song; Dong-Won Shin; Dong-Yeul Kwon
Journal:  Exp Ther Med       Date:  2016-03-31       Impact factor: 2.447

6.  Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing.

Authors:  Su-Hyun Mun; Ok-Hwa Kang; Dae-Ki Joung; Sung-Bae Kim; Yun-Soo Seo; Jang-Gi Choi; Young-Seob Lee; Seon-Woo Cha; Young-Sup Ahn; Sin-Hee Han; Dong-Yeul Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-10       Impact factor: 2.629

7.  Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran.

Authors:  Ahya Abdi-Ali; Saghar Hendiani; Parisa Mohammadi; Sara Gharavi
Journal:  Jundishapur J Microbiol       Date:  2014-01-01       Impact factor: 0.747

8.  In vitro anti-MRSA activity of carvone with gentamicin.

Authors:  Su-Hyun Mun; Ok-Hwa Kang; Dae-Ki Joung; Sung-Bae Kim; Jang-Gi Choi; Dong-Won Shin; Dong-Yeul Kwon
Journal:  Exp Ther Med       Date:  2014-01-23       Impact factor: 2.447

9.  Ethanol Extract of Ulmus pumila Root Bark Inhibits Clinically Isolated Antibiotic-Resistant Bacteria.

Authors:  Yong-Ouk You; Na-Young Choi; Kang-Ju Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-08       Impact factor: 2.629

10.  In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea.

Authors:  Nishanth Kumar Sasidharan; Sreerag Ravikumar Sreekala; Jubi Jacob; Bala Nambisan
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.